This is a patient demand report for spine and pain practice owners and marketing leads. It shows what patients pay for a spinal cord stimulator and for another back operation, what the evidence says, and what they find when they search before they call. The practice-side facts come first; the patient detail below is the evidence behind them.
For practice owners: what this search looks like from your side
Some facts, side by side.
For 2026, Medicare’s national surgeon fee is $375.43 for placing stimulator leads through a needle and $318.64 for placing the battery. A single-level combined lumbar fusion pays the surgeon $1,700.11. The facility side runs the other way: a hospital outpatient department is paid $31,526 for the stimulator battery encounter and $27,722 for the fusion. (Medtronic SCS guide, 2026, Medtronic spine guide, 2026)
The randomized trial of a stimulator against a repeat operation that patients find is from 2005, with 50 patients. Its cost follow-up, published in 2007, was the first result when I searched this comparison. (Neurosurgery, 2007)
In a 2023 claims study of 7,560 matched commercial and Medicare Advantage patients, total costs in the first year were $39,000 higher with a stimulator than with conventional care, and similar in the second year. (JAMA Neurology, 2023)
A 2026 meta-analysis of 38 studies put the share of patients who did not get past the trial at 16.2%, and explant rates at 4.0%, 7.0% and 11.9% at one, two and three years. (Neuromodulation, 2026)
What those mean together for your practice is for you to work out. If you advertise spine procedures, my page on Google Ads costs for spine surgeons covers the paid side.
If you want to see how your spine and pain pages answer that question today, book a 30-minute call. I will look at your site and your market before we talk. You can also read what a page like this is worth to an orthopedic practice.
What patients pay
When I reviewed the pages that rank for this comparison on 4 October 2026, the only head-to-head dollar figures came from that 2007 trial analysis. The rest were pain practice pages pricing the stimulator on its own, a 2011 workers’ compensation cost study, a medical journal blog questioning the evidence, a news explainer, and a guide for personal injury lawyers. None put current Medicare rates for both paths on one page.
So a patient weighing a stimulator against another operation assembles the numbers from separate places. The cash prices they find look like this.
On MDsave, a site where patients prepay a set price, listings for a stimulator with leads placed through a needle ran from $10,075 to $82,858 when I checked on 4 October 2026. The listing does not say whether the trial is included. Inpatient lumbar fusion listings ran from $36,282 to $141,059. (stimulator, lumbar fusion)
The trial matters to the patient’s bill. A stimulator is usually tested first with temporary leads before the permanent system goes in, so a patient pays for two procedures, and some never reach the second.
Insured patients pay a share of the negotiated rate, set by their deductible and coinsurance, so few of them ever see the cash figures above. They do see them while comparing practices online.
What Medicare pays your practice
Medicare pays the facility and the surgeon separately, so the figures add together.
| Stimulator, leads through a needle | Stimulator battery | Lumbar decompression | Single-level lumbar fusion | |
|---|---|---|---|---|
| Procedure code | CPT 63650 | CPT 63685 | CPT 63047 | CPT 22633 |
| Medicare 2026 surgeon fee, facility | $375.43 | $318.64 | $1,065.49 | $1,700.11 |
| Medicare 2026 hospital outpatient | $6,511 | $31,526 | $7,413 | $27,722 |
| Medicare 2026 surgery center | $5,031 | $27,486 | $3,696 | $20,841 |
Surgeon fees come from the CMS 2026 Physician Fee Schedule (October release): national facility rates, the national average before geographic adjustment. Facility rates come from Medtronic’s 2026 spinal cord stimulation guide and 2026 spinal procedures guide, which cite the CMS 2026 rules. Medtronic sells stimulators and spine implants.
When the lead placement is done in an office as a trial, the 2026 national rate for the physician is $2,388.50.
In a hospital outpatient department, the stimulator implant is paid as one comprehensive payment, with other services on the claim packaged in. With the battery encounter at $31,526, a permanent system there comes to about $32,220 with both surgeon fees. In a surgery center both parts are paid in full, so it comes to about $33,211 ($5,031 plus $27,486 plus $694 in surgeon fees).
A single-level fusion in a hospital outpatient department comes to about $29,422 ($27,722 plus $1,700), and in a surgery center about $22,541. A decompression without fusion in a surgery center comes to about $4,761.
Inpatient stays are paid by group. A whole stimulator system placed for a nervous system diagnosis groups to $24,825, the group Medicare names for spinal neurostimulators. A single-level fusion without major complications groups to $23,507. A decompression without complications or comorbidities groups to $10,871.
The surgeon’s fee for a stimulator is about $694 against $1,700 for a fusion. The facility side is where the stimulator is paid, because the device is paid out of the facility’s share.
What the evidence patients read says
Patients who research this find a small trial in favor of the stimulator, larger studies that are less favorable, and reviews that disagree.
Stimulator against a repeat operation. In the 2005 trial, patients with leg pain that persisted after lumbar surgery were randomized to a stimulator or another operation. Among 45 patients followed, the stimulator succeeded in 9 of 19 against 3 of 26 for reoperation, and those given reoperation needed more opioids. (Neurosurgery, 2005) The cost analysis found mean per-patient costs of $31,530 for the stimulator and $38,160 for reoperation, intention to treat, at a mean of 3.1 years. 62% of reoperation patients crossed over to a stimulator, against 26% the other way, and none who crossed to reoperation succeeded. (Neurosurgery, 2007)
Stimulator against medical care. A 100-patient trial in the same group of patients found 48% of the stimulator group reached half or better leg pain relief at six months, against 9% on medical management alone. By 12 months, 32% of stimulator patients had had a device complication. (Pain, 2007)
Real-world cohorts. In 158 workers’ compensation patients, the mean medical cost per stimulator patient over 24 months was $52,091, and the authors found it was not cost-effective in that group. (Spine, 2011) The 2023 claims study found 17.9% had stimulator complications within two years and 22.1% had revisions or removals. Stimulator patients were less likely to have spine surgery in the first year, with no difference in the second. (JAMA Neurology, 2023)
Durability. A 2025 review of 13,026 implanted patients found 9.82% were explanted. Lack of pain relief was the most common reason, at 38%, followed by lead failure and infection. (Journal of Pain Research, 2025) In the 2026 meta-analysis, 44.7% of permanent implant patients had either been explanted or reported less than half pain relief by three years. (Neuromodulation, 2026)
Low back pain. A 2023 Cochrane review of 13 studies found the data did not support stimulators for low back pain outside a clinical trial. That review covered low back pain, mostly in trials against placebo, not leg pain after failed surgery specifically. (Cochrane, 2023)
Who patients are
The stimulator-or-reoperation choice applies mostly to patients who have already had back surgery and still have pain. Both trials above enrolled patients with persistent leg pain after lumbar surgery, which is the group the stimulator-or-reoperation choice applies to.
In the 2023 claims study, the matched patients averaged 63.5 years of age and 59.3% were women. Their diagnoses included failed back surgery syndrome, complex regional pain syndrome and chronic postsurgical back pain. (JAMA Neurology, 2023)
A stimulator places thin leads over the spinal cord, powered by a battery under the skin, to change how pain signals are felt. A reoperation decompresses or fuses the spine again. The two are often offered by different specialists, pain physicians for the stimulator and spine surgeons for the operation, which is why patients compare them online before either appointment.
Questions patients ask before they book
These are the questions your page and your front desk need to answer.
- Does the patient pay for the trial and the implant separately? A good page explains both steps and what happens if the trial fails.
- Why does the stimulator bill look as large as a fusion? A good page splits the device, facility and surgeon costs.
- What will the patient owe on Medicare, on a commercial plan, or paying cash? A good page answers all three, or says who on staff will.
- What happens if the device stops helping? A good page links the explant data and states the revision and removal path.
- How many implants or fusions does the physician do a year? A good page states the physician’s own volume.
For the cost of each path on its own, my pages on spinal cord stimulator cost, lumbar fusion surgery cost and disc replacement vs fusion cost show what patients find for each search.
What a page that wins this search includes
- Both paths on one page, priced side by side with current rates, because the top result is a 2007 trial.
- The trial and the permanent implant priced as two steps, with the trial failure rate shown.
- Medicare, commercial and self-pay explained separately, with the facility and surgeon split shown.
- The physician’s annual volume and which specialist does which procedure.
- The evidence linked, including the explant and Cochrane findings, stated neutrally and left disputed where it is disputed.
Frequently asked questions
Is a spinal cord stimulator cheaper than back surgery? It depends on the operation. Medicare’s 2026 national averages put a permanent stimulator in a surgery center at about $33,211 for facility and surgeon together, against about $22,541 for a single-level fusion and about $4,761 for a decompression.
Does Medicare cover spinal cord stimulators and back surgery? Both have 2026 Medicare payment rates in hospitals, hospital outpatient departments and surgery centers. Coverage for an individual patient depends on meeting the medical criteria.
Which works better after failed back surgery? In the randomized comparison patients find, with 50 patients, the stimulator succeeded more often than reoperation and cost less per patient. Larger real-world studies found higher costs and frequent device complications.
How often are spinal cord stimulators removed? A 2026 meta-analysis put explant rates at 4.0% after one year and 11.9% after three. A 2025 review of 13,026 patients found 9.82% were explanted.
Why do prices for these procedures vary so much? Setting and device drive most of it. On MDsave, listed cash prices for a stimulator ran from $10,075 to $82,858, and for an inpatient lumbar fusion from $36,282 to $141,059.
